14-day Premium Trial Subscription Try For FreeTry Free
Pioneering a Precision Approach to Cardiovascular Medicine Corporate Presentation - March 2020 forward-looking statement … | March 5, 2020
Asymmetry Capital Management L.P. decreased its stake in shares of Myokardia Inc (NASDAQ:MYOK) by 51.9% during the fourth quarter, HoldingsChannel reports. The firm owned 23,023 shares of the biotechn
Myokardia (NASDAQ:MYOK)‘s stock had its “buy” rating reissued by stock analysts at Cowen in a report released on Thursday, AnalystRatings.com reports. They currently have a $104.00 price objecti
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE